Medinol products

Ridaforolimus Eluting Coronary Stent System; Excellent clinical outcomes. Redefining deliverability with a new spring tip. Low footprint cobalt-chromium design. Optimal conformability and vessel support. Elastomeric coating and outstanding surface integrity. Eluting Ridaforolimus, a high therapeutic index limus drug.

The Ideal Post-Dilatation Balloon; Unique, tapered Flexx² spring tip purposefully designed for enhanced pushability and flexibility. Easily navigates through stent struts to side branches. The tapered spring tip was designed to closely track the guidewire and eliminate flare-out and buckling common to plastic tips. The only radiopaque tip, enabling visualization of the catheter-tip location during procedure. Extended hydrophilic coating for superior crossability.

Carefully read all instructions, warnings and precautions prior to use. Failure to do so may result in complications. The Gallant™ PTCA Dilatation Catheter is a combination of single lumen and dual lumen catheter, comprising an expandable semi-compliant balloon on a rapid exchange (RX) catheter. It is an RX design, and is therefore assembled from a combination of single lumen and dual lumen tubing. One lumen, which starts at the catheter`s proximal side and ends at the balloon, is used for inflation of the balloon with 50% contrast medium diluted 1:1 with normal saline. The second lumen, from the RX-port section to the distal tip, permits the use of a guide wire to facilitate advancement of the Gallant to and through the stenosis to be dilated. The distal shaft of the Gallant including the folded balloon is coated with a hydrophilic coating.

ChampioNIR is a hybrid stent combining Nitinol alloy structure with an elastomer micro-fiber mesh. Fracture resistance during contraction, compression, torsion, extension and flexion. Outstanding radial support and conformability to the vessel natural form and motion. Unique delivery system for accurate stent deployment. Superior flexibility for better deliverability. ChampioNIR is the first peripheral stent to offer a viable option for long-term stenting of peripheral arteries.

WiZeCell, our proprietary stent design is paradigm shift in cardiovascular stenting. The design’s sixth generation, the EluNIR drug eluting stent, relieves physicians from compromising between vessel conformability, scaffolding integrity, uniform drug distribution and radial support by offering an integrated design maximizing all benefits simultaneously.